Research Paper Volume 16, Issue 3 pp 2563—2590
Integrative analysis confirms TPX2 as a novel biomarker for clinical implication, tumor microenvironment, and immunotherapy response across human solid tumors
Figure 8. The relationship between TPX2 expression and clinical parameters in various cancers from TCGA database. (A) The relationship between TPX2 expression and age. (B) The relationship between TPX2 expression and gender. (C) The relationship between TPX2 expression and the pathological stages of cancers. *p< 0.05, **p< 0.01, ***p< 0.001.